NO20025638D0 - Farmasöytisk kombinasjon av bikalutamid og tamoxifen for å tilveiebringe enanti-androgen effekt og en anti-östrogen effekt - Google Patents

Farmasöytisk kombinasjon av bikalutamid og tamoxifen for å tilveiebringe enanti-androgen effekt og en anti-östrogen effekt

Info

Publication number
NO20025638D0
NO20025638D0 NO20025638A NO20025638A NO20025638D0 NO 20025638 D0 NO20025638 D0 NO 20025638D0 NO 20025638 A NO20025638 A NO 20025638A NO 20025638 A NO20025638 A NO 20025638A NO 20025638 D0 NO20025638 D0 NO 20025638D0
Authority
NO
Norway
Prior art keywords
effect
bicalutamide
tamoxifen
pharmaceutical combination
androgenic
Prior art date
Application number
NO20025638A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025638L (no
Inventor
Barrington Furr
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20025638D0 publication Critical patent/NO20025638D0/no
Publication of NO20025638L publication Critical patent/NO20025638L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20025638A 2000-05-23 2002-11-22 Farmasöytisk kombinasjon av bikalutamid og tamoxifen for å tilveiebringe enanti-androgen effekt og en anti-östrogen effekt NO20025638L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012291.1A GB0012291D0 (en) 2000-05-23 2000-05-23 Pharmaceutical combination
PCT/SE2001/001162 WO2001089515A1 (en) 2000-05-23 2001-05-22 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect

Publications (2)

Publication Number Publication Date
NO20025638D0 true NO20025638D0 (no) 2002-11-22
NO20025638L NO20025638L (no) 2002-11-22

Family

ID=9892038

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025638A NO20025638L (no) 2000-05-23 2002-11-22 Farmasöytisk kombinasjon av bikalutamid og tamoxifen for å tilveiebringe enanti-androgen effekt og en anti-östrogen effekt

Country Status (23)

Country Link
US (1) US20030134899A1 (pt)
EP (1) EP1292296A1 (pt)
JP (1) JP2003534278A (pt)
KR (1) KR20030001535A (pt)
CN (1) CN1431899A (pt)
AU (1) AU2001262833A1 (pt)
BR (1) BR0111051A (pt)
CA (1) CA2407028A1 (pt)
CZ (1) CZ20023785A3 (pt)
EE (1) EE200200654A (pt)
GB (1) GB0012291D0 (pt)
HK (1) HK1053061A1 (pt)
HU (1) HUP0302276A3 (pt)
IL (1) IL152545A0 (pt)
IS (1) IS6589A (pt)
MX (1) MXPA02011472A (pt)
NO (1) NO20025638L (pt)
NZ (1) NZ521979A (pt)
PL (1) PL363504A1 (pt)
RU (1) RU2002134483A (pt)
SK (1) SK16562002A3 (pt)
WO (1) WO2001089515A1 (pt)
ZA (1) ZA200208845B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103838D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
US20050080143A1 (en) * 2001-11-29 2005-04-14 Steiner Mitchell S. Treatment of androgen-deprivation induced osteoporosis
US20060269611A1 (en) * 2001-11-29 2006-11-30 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
EP1666033B1 (en) * 2001-11-29 2008-12-31 GTX, Inc. Prevention and treatment of androgen-deprivation induced osteoporosis
US20070197664A1 (en) * 2001-11-29 2007-08-23 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US20080249183A1 (en) * 2001-11-29 2008-10-09 Steiner Mitchell S Treatment of androgen-deprivation induced osteoporosis
US20040214898A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S. Methods for treating hot flashes
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
GB0424339D0 (en) * 2004-11-03 2004-12-08 Astrazeneca Ab Combination therapy
CA2582195A1 (en) * 2005-03-29 2006-10-05 Usv Limited Process for preparation of bicalutamide
CN114748480B (zh) * 2021-01-08 2023-10-20 轩竹生物科技股份有限公司 一种预防和/或治疗癌症的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637389A (pt) * 1962-09-13
DE3372965D1 (en) * 1982-07-23 1987-09-17 Ici Plc Amide derivatives
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
EP0748220A4 (en) * 1994-01-21 1997-09-10 Sepracor Inc METHOD AND COMPOSITIONS FOR TREATING ANDROGEN-DEPENDENT DISEASES USING OPTICALLY PURE R - (-) CASODEX

Also Published As

Publication number Publication date
JP2003534278A (ja) 2003-11-18
MXPA02011472A (es) 2004-09-06
NZ521979A (en) 2004-06-25
CA2407028A1 (en) 2001-11-29
US20030134899A1 (en) 2003-07-17
IS6589A (is) 2002-10-25
CZ20023785A3 (cs) 2003-03-12
NO20025638L (no) 2002-11-22
PL363504A1 (en) 2004-11-29
SK16562002A3 (sk) 2003-05-02
ZA200208845B (en) 2004-02-27
CN1431899A (zh) 2003-07-23
RU2002134483A (ru) 2004-06-27
AU2001262833A1 (en) 2001-12-03
IL152545A0 (en) 2003-05-29
HK1053061A1 (zh) 2003-10-10
GB0012291D0 (en) 2000-07-12
KR20030001535A (ko) 2003-01-06
HUP0302276A3 (en) 2005-06-28
BR0111051A (pt) 2003-04-15
WO2001089515A1 (en) 2001-11-29
EP1292296A1 (en) 2003-03-19
HUP0302276A2 (hu) 2003-11-28
EE200200654A (et) 2004-06-15

Similar Documents

Publication Publication Date Title
EE05216B1 (et) Pregabaliini asmmeetriline sntees
ATE258918T1 (de) Kristallform alpha des perindopril-tert- butylaminsalzes
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DE69904208T2 (de) Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure
DE60132525D1 (de) Schlagzäh-modifizierer und diese modifizierer enthaltende polyesterzusammensetzung
ATE306481T1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
NO20013770D0 (no) Metoder og blandinger for å öke antall hvite blodceller
ATE453391T1 (de) Östrogene mittel enthaltende arzneizusammensetzungen
DK1294644T3 (da) Vandbehandlingssammensætninger
ATE447972T1 (de) Darreichungsform zur hormonalen kontrazeption
NO20025638D0 (no) Farmasöytisk kombinasjon av bikalutamid og tamoxifen for å tilveiebringe enanti-androgen effekt og en anti-östrogen effekt
DE60113100D1 (de) Emulsion und wasserabstossende zusammensetzung
EE200200393A (et) Glüburiidi ravimkoostis
ID30187A (id) Dongkrak jenis pantagraf
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
IS6766A (is) Pravastatínnatríum, að mestu leyti laust við pravastatínlaktón og epí-pravastatín, og blöndur sem innihalda það
NO20004818D0 (no) Stabile doseringsformer av fluoxetin og dets enantiomere
ATE232378T1 (de) Reinigungspflaster zur verbesserung des hautzustandes
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
PT1263421E (pt) Avasimibe, o inibidor duplo da sintese de ester de colesterilo e de ester ceroso, para o tratamento de disturbios da glandula sebacea
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
DE60139151D1 (de) Haarwuchshemmer und diese enthaltende zusammensetzungen
IS8106A (is) Samsetning makrólíðs og staðdeyfingarlyfs til að meðhöndla húðsjúkdóma
NO20031537L (no) Nye farmasöytiske blandinger inneholdende epinastin og pseudoefedrin
AU2002239417A1 (en) Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application